ZKIN ZKIN
Company Profile ↓Company Overview
ZKIN (ZKIN) is a publicly traded company listed on with a market capitalization of $7.54M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Sep 2025 Revenue of $71.24M (-34.2% YoY); net profit $-3.99M.
- Trailing 12 Months Year-on-year growth — revenue -34.2%.
- 5-Year Trend Long-term compounding — revenue CAGR -11.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -11.39% |
| 1 Year: | -34.16% |
Stock Price Performance
| 1 Year: | -47.34% |
| 6 Months: | -44.12% |
| 3 Months: | -24.50% |
| 1 Month: | +7.55% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)47.16 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -11.4% CAGR over 5 years.
- Trading 63.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 102.39M | 111.60M | 108.20M | 71.24M |
| Cost of Revenue | - | 94.80M | 110.30M | 101.65M | 67.20M |
| Gross Profit | - | 7.60M | 1.30M | 6.55M | 4.04M |
| Operating Expenses | - | 8.79M | 8.54M | 7.67M | 6.54M |
| Operating Income | - | -1.19M | -7.24M | -1.12M | -2.50M |
| EBITDA | - | -2.44M | -59.19M | -689.44K | -2.82M |
| Interest Expense | - | 3.45M | 1.58M | 1.23M | 330.23K |
| Pretax Income | - | -7.40M | -61.75M | -2.77M | -4.02M |
| Tax Provision | - | -1.34M | -459.86K | 12.11K | -948 |
| Net Income | - | -6.08M | -61.06M | -2.78M | -3.99M |
| Diluted EPS | -1.19 | -1.47 | -10.76 | -0.57 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 128.92M | 58.67M | 79.99M | 62.87M |
| Current Assets | - | 66.77M | 43.25M | 62.74M | 45.75M |
| Cash & Equivalents | - | 7.52M | 4.99M | 4.01M | 2.31M |
| Inventory | - | 21.14M | 17.94M | 13.53M | 13.08M |
| Receivables | - | 28.36M | 14.97M | 22.39M | 23.09M |
| Total Liabilities | - | 43.86M | 33.43M | 51.67M | 38.25M |
| Current Liabilities | - | 43.85M | 24.89M | 49.87M | 31.88M |
| Long Term Debt | - | - | 8.53M | 1.80M | 6.32M |
| Total Debt | - | 20.33M | 22.00M | 26.88M | 27.53M |
| Total Equity | - | 84.68M | 25.08M | 28.16M | 24.50M |
| Shares Outstanding | - | 4.34M | 4.71M | 5.16M | 6.61M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -2.07M | -1.91M | -6.88M | 736.40K |
| Investing Cash Flow | - | -2.11M | -2.29M | -2.35M | -651.99K |
| Financing Cash Flow | - | -969.96K | 2.07M | 7.22M | 478.45K |
| Capital Expenditure | - | -2.11M | -2.29M | -603.05K | -651.99K |
| Free Cash Flow | - | -4.18M | -4.20M | -7.48M | 84.41K |
| Net Change in Cash | - | -5.15M | -2.13M | -2.01M | 562.86K |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 7.4% | 1.2% | 6.1% | 5.7% |
| Operating Margin % | - | -1.2% | -6.5% | -1.0% | -3.5% |
| Net Margin % | - | -5.9% | -54.7% | -2.6% | -5.6% |
| ROE % | - | -7.2% | -243.5% | -9.9% | -16.3% |
| ROCE % | - | -1.4% | -21.4% | -3.7% | -8.1% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ZKIN
ZK International Group Co., Ltd. Announces Earnings Results for the First Half of Fiscal Year 2025
ZK International Group Co., Ltd. (ZKIN) ("ZK International" or the "Company"), a designer, engineer, manufacturer, and supplier of patented high-performance stainless steel and carbon steel pipe products primarily used for water and gas sup…
ZKIN — Frequently Asked Questions
What is the current share price of ZKIN?
As of 2026-09-16 18:39 PDT, ZKIN trades at $1.14 on NASDAQ/NYSE. Its 52-week range is $1.01 to $3.09.
What is the market capitalisation of ZKIN?
ZKIN has a market capitalisation of $7.54M on NASDAQ/NYSE.
What is the P/E ratio of ZKIN?
ZKIN trades at a trailing price-to-earnings (P/E) ratio of -2.00. Its price-to-book (P/B) ratio is 0.31.
What is the return on equity (ROE) of ZKIN?
ZKIN has a return on equity (ROE) of -16.27%. Its return on capital employed (ROCE) is -8.05%.
Is ZKIN a good stock to buy?
This page provides a data-driven analysis of ZKIN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.